Pink Sheet Podcast: Insys Divests Opioids, Pretomanid's Advisory Committee Meeting, And Biosimilar User Fee Collections
Executive Summary
Our discussion of the Insys corporate integrity agreement and bankruptcy filling, US FDA's advisory committee meeting on the TB treatment pretomanid, and new data showing lower US biosimilar user fee collections than expected.